FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

5 letters match. Newest first.

  1. ASP Global, LLC. dba Anatomy Supply Partners, LLC.

    FDA cites ASP Global for quality-system, reporting, and unapproved-change violations involving Safe-T-Fill blood collection devices.

    High risk
  2. Annovex Pharma, Inc.

    FDA warns outsourcing facility Annovex Pharma in Lorton, VA, over contaminated sterile drug production and missed FDA reports.

    High risk
  3. Bioptimal International

    Bioptimal International made unapproved changes to heart catheters and lacked quality and reporting controls.

    High risk
  4. Miami University Department of Chemistry and Biochemistry

    Miami University contract testing lab falsified heparin API test data and lacked CGMP controls.

    High risk
  5. North American Hirudin Biotech Products Inc.

    FDA warned North American Hirudin Biotech Products that Hirudin and Red 65 are unapproved drugs sold with disease-treatment claims.

    High risk